During the corresponding time, Cbdmd Inc recorded a revenue increase by 20.56 % year on year, sequentially revenue fell by -1.53 %. While revenue at the Cbdmd Inc 's corporate clients
Cbdmd Inc's Comment on Sales, Marketing and Customers
cbdMD, Inc. operates in the consumer wellness market, focusing on supplement brands that utilize natural compounds, primarily hemp-derived cannabinoids. Their product offerings include broad-spectrum and full-spectrum CBD formulations, hemp-derived Delta-9 THC products where legally permitted, and functional products designed to address wellness needs such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. The company's multi-brand portfolio features the flagship cbdMD® line, which includes oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. cbdMD, Inc. also serves the pet wellness market through Paw CBD®, offering tinctures, chews, and topicals for dogs and cats. Additionally, their ATRX® platform focuses on performance-driven nutraceutical and nootropic categories, incorporating emerging non-cannabinoid functional ingredients such as functional mushrooms. The Herbal Oasis (“Oasis”) brand is identified as a premium hemp-derived brand.
Cbdmd Inc’s Comment on Sales, Marketing and Customers
cbdMD, Inc. operates in the consumer wellness market, focusing on supplement brands that utilize natural compounds, primarily hemp-derived cannabinoids. Their product offerings include broad-spectrum and full-spectrum CBD formulations, hemp-derived Delta-9 THC products where legally permitted, and functional products designed to address wellness needs such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. The company's multi-brand portfolio features the flagship cbdMD® line, which includes oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. cbdMD, Inc. also serves the pet wellness market through Paw CBD®, offering tinctures, chews, and topicals for dogs and cats. Additionally, their ATRX® platform focuses on performance-driven nutraceutical and nootropic categories, incorporating emerging non-cannabinoid functional ingredients such as functional mushrooms. The Herbal Oasis (“Oasis”) brand is identified as a premium hemp-derived brand.
Sources:
Cbdmd Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Cbdmd Inc’s corporate clients.
For your research, we’ve provided 9 tables on Cbdmd Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
